The FDA approved omidubicel on December 8, 2025, the same day parent company Ayrmid announced positive results at the 2025 American Society of Hematology Annual Meeting. FDA approved omidubicel-onlv ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback